Xuan Q. Liang
No. 277 Yanta West Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Retraction notice to "miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1" [Biomedicine & Pharmacotherapy 108 (2018) 574-583].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 22, 2026
The effects of brain radiotherapy combined with immunotherapy and chemotherapy for driver gene-negative non-small-cell lung cancer with brain metastases.
Journal: Frontiers in oncology
Published: December 09, 2025
A Population-Based Nomogram for Predicting Overall Survival in Pulmonary Sarcomatoid Carcinoma With Real-World External Validation.
Journal: Cancer medicine
Published: December 02, 2025
Metabolomic Revelations into the Dynamic Transformations Across Various Developmental Stages of Coprinus comatus Through UHPLC-Q-Orbitrap-HRMS Analysis.
Journal: Metabolites
Published: September 03, 2025
Identification of MDM4 as a Prognostic Biomarker and a Target for Therapeutics in Colorectal Cancer.
Identification of MDM4 as a Prognostic Biomarker and a Target for Therapeutics in Colorectal Cancer.
Journal: Biotechnology and applied biochemistry
Published: March 07, 2025
Invasive aspergillosis complicated in a patient with non-small cell lung cancer harboring RET fusion during treatment with RET-TKIs: a case report and literature review.
Journal: Frontiers in oncology
Published: May 13, 2024
Long-term impact of COVID-19 in patients with lung cancer receiving immune checkpoint inhibitors: a multicenter cohort study during Omicron pandemic.
Journal: BMC infectious diseases
Published: March 31, 2024
Alectinib continuation beyond progression in ALK-positive non-small cell lung cancer with alectinib-refractory.
Journal: Translational lung cancer research
Published: December 01, 2023
Platinum-based neoadjuvant chemotherapy upregulates STING/IFN pathway expression and promotes TILs infiltration in NSCLC.
Journal: Frontiers in oncology
Published: November 29, 2023
Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China.
Journal: Clinical and translational medicine
Published: August 14, 2023
A novel risk classifier to predict the in-hospital death risk of nosocomial infections in elderly cancer patients.
Journal: Frontiers in cellular and infection microbiology
Published: March 05, 2023
Construction and Evaluation of Clinical Prediction Model for Immunotherapy-related Adverse Events and Clinical Benefit in Cancer Patients Receiving Immune Checkpoint Inhibitors Based on Serum Cytokine Levels.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 06, 2023
Last Updated: 09/26/2026